10X Genomics Preferred Securities out of Shareholders Equity (Quarterly) Insights

10X Genomics, Inc. (TXG)

22.13 +2.47 (+12.56%) USD | NASDAQ | Feb 26, 16:00

21.70 -0.43 (-1.94%) After-Hours: 19:46

View Preferred Securities out of Shareholders Equity (Quarterly) for TXG.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Omnicell, Inc.	--
American Shared Hospital Services	--
WW International, Inc.	--
Novo Integrated Sciences, Inc.	--
Pacific Health Care Organization, Inc.	--